Skip to main content
Equibles
CCCC logo

CCCC · C4 Therapeutics, Inc. · Webcasts, Transcripts & Audio

Track CCCC — free

Use CCCC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CCCC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.16 +0.00 (+0.00%)
Russell 2000 member Rebalance outlook locked
Market Cap
$388.76M
Shares
123.03M
Volume · Oct 20 3.69M Avg daily vol (3M) 2.37M

C4 Therapeutics, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for C4 Therapeutics, Inc. (CCCC), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Conference
Investor event
2026-09-10
C4 Therapeutics, Inc. (CCCC) September 10, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Investor Update
Investor event
2026-06-18
C4 Therapeutics, Inc. (CCCC) June 18, 2026 Investor Update Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-04
C4 Therapeutics, Inc. (CCCC) June 4, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-26
C4 Therapeutics, Inc. (CCCC) Q1 2026 Earnings Call
Revenue
$6.15M
▼ 15% YoY
Diluted EPS
$-0.20
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
C4 Therapeutics, Inc. (CCCC) Q2 2025 Earnings Call
Revenue
$6.46M
▼ 46.2% YoY
Diluted EPS
$-0.37
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-01-14
C4 Therapeutics, Inc. (CCCC) Q4 2024 Earnings Call
Revenue
$5.18M*
▲ 58.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-31
C4 Therapeutics, Inc. (CCCC) Q3 2024 Earnings Call
Revenue
$15.36M
▲ 38.7% YoY
Diluted EPS
$-0.35
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
C4 Therapeutics, Inc. (CCCC) Q2 2024 Earnings Call
Revenue
$12.01M
▲ 350.7% YoY
Diluted EPS
$-0.26
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–8 of 8 webcasts
Key facts CIK 1662579 CUSIP 12529R107 13F (30d) 9 filings 9 filers Visit website Investor relations